Drugs / AIO-001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06170827 | Nov 2023 → Jul 2024 | respiratory system disorder | Syneos Health | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AIO-001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06170827 ↗ |
| Route | Subcutaneous | “AIO-001 Subcutaneous (SC) injection will be administered.” NCT06170827 ↗ |